These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35346066)

  • 1. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study.
    Shaffer SR; Nugent Z; Bernstein CN; Walkty A; Singh H
    BMC Gastroenterol; 2022 Mar; 22(1):140. PubMed ID: 35346066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study.
    Singh H; Nugent Z; Yu BN; Lix LM; Targownik L; Bernstein C
    PLoS One; 2017; 12(2):e0171266. PubMed ID: 28199401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
    Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile infections in Alberta: The validity of administrative data using ICD-10 diagnostic codes for CDI surveillance versus clinical infection surveillance.
    Pfister T; Rennert-May E; Ellison J; Bush K; Leal J
    Am J Infect Control; 2020 Dec; 48(12):1431-1436. PubMed ID: 32810568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
    Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
    Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
    Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends and predictors of laboratory-confirmed recurrent and severe
    Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
    CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
    Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
    J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study.
    Kuenzig ME; Benchimol EI; Bernstein CN; Bitton A; Carroll MW; Griffiths AM; Kaplan GG; Nguyen GC; Otley AR; Stukel TA; Dummer TJB; El-Matary W; Jacobson K; Jones JL; Lix LM; Mack DR; Murthy SK; Peña-Sánchez JN; Targownik LE; Fung SG; Spruin S; Coward S; Cui Y; Filliter C; Nugent Z; Siddiq S; Singh H;
    J Pediatr Gastroenterol Nutr; 2022 Aug; 75(2):173-180. PubMed ID: 35675701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.
    Fang SB; Song YQ; Zhang CY; Wang LB
    World J Pediatr; 2022 Jan; 18(1):27-36. PubMed ID: 34800281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis.
    Maharshak N; Barzilay I; Zinger H; Hod K; Dotan I
    Medicine (Baltimore); 2018 Feb; 97(5):e9772. PubMed ID: 29384868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.
    Drozdinsky G; Atamna A; Banai H; Ben-Zvi H; Bishara J; Eliakim-Raz N
    Medicine (Baltimore); 2023 Feb; 102(6):e32812. PubMed ID: 36820599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease.
    Saffouri G; Gupta A; Loftus EV; Baddour LM; Pardi DS; Khanna S
    Scand J Gastroenterol; 2017 Nov; 52(11):1240-1247. PubMed ID: 28782372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
    Reasoner SA; Nicholson MR
    Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease.
    Abdehagh M; Azimirad M; Houri H; Nadalian B; Azimirad F; Olfatifar M; Nasir Shoeibi OK; Yadegar A; Shahrokh S; Mahdavi Roshan M; Asadzadeh Aghdaei H; Zali MR
    BMC Infect Dis; 2021 Oct; 21(1):1103. PubMed ID: 34702217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
    Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
    Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.